FloLipid Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with FloLipid
I
- Ibrance (palbociclib)
- Iclusig (ponatinib)
- Idacio (adalimumab)
- idelalisib
- Idhifa (enasidenib)
- Ilaris (canakinumab)
- Ilosone (erythromycin)
- imatinib
- Inbrija (levodopa)
- Incivek (telaprevir)
- indinavir
- Infergen (interferon alfacon-1)
- Inflectra (infliximab)
- infliximab
- Infumorph (morphine)
- Inrebic (fedratinib)
- Intelence (etravirine)
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-2b / ribavirin
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- Intron A (interferon alfa-2b)
- Invirase (saquinavir)
- iodoquinol
- ipilimumab
- isavuconazonium
- IsonaRif (isoniazid / rifampin)
- isoniazid
- isoniazid / pyrazinamide / rifampin
- isoniazid / rifampin
- Isoptin (verapamil)
- Isoptin IV (verapamil)
- Isoptin SR (verapamil)
- isradipine
- Isturisa (osilodrostat)
- itraconazole
- ivacaftor
- ivacaftor / lumacaftor
- ivacaftor / tezacaftor
- ivosidenib
- ixabepilone
- ixazomib
- ixekizumab
- Ixempra (ixabepilone)
- Ixifi (infliximab)
More about FloLipid (simvastatin)
- FloLipid consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Latest FDA alerts (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: statins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.